1. Chemotherapy of advanced NSCLC in special patient population;Gridelli;Ann. Oncol.,2006
2. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†[published online ahead of print, 2023 Jan 3];Hendriks;Ann. Oncol.,2023
3. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†[published online ahead of print, 2023 Jan 3];Hendriks;Ann. Oncol.,2023
4. Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer;Hong;Ther. Adv. Med. Oncol.,2021
5. Capmatinib in MET exon 14 skipping mutation-positive lung adenocarcinoma with extensive central nervous system metastasis;Kim;Onco. Targets Ther.,2022